Literature DB >> 1460149

Comorbidity of personality disorders and depression: implications for treatment.

M T Shea1, T A Widiger, M H Klein.   

Abstract

This article reviews naturalistic and controlled studies of the impact of comorbidity of personality disorders and depression on response to various forms of treatment. The findings support the common belief that personality disorders are associated with a poorer response to treatment for depression. In contrast, the limited data available suggest that the presence of depression may be a positive prognostic indicator for patients with borderline and antisocial personality disorder. There are insufficient data to draw conclusions regarding the influence of specific types of personality disorders on outcome with specific forms of treatment for depression. More specific assessment of personality disorders, particularly of possible underlying dimensions, is likely to be a more fruitful approach than the currently used categorical approach in identifying effective treatments for patients with personality disorders and depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1460149     DOI: 10.1037//0022-006x.60.6.857

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  24 in total

Review 1.  Stability and course of personality disorders: the need to consider comorbidities and continuities between axis I psychiatric disorders and axis II personality disorders.

Authors:  C M Grilo; T H McGlashan; A E Skodol
Journal:  Psychiatr Q       Date:  2000

2.  The impact of comorbid dysthymic disorder on outcome in personality disorders.

Authors:  David J Hellerstein; Andrew E Skodol; Eva Petkova; Hui Xie; John C Markowitz; Shirley Yen; John Gunderson; Carlos Grilo; Maria T Daversa; Thomas H McGlashan
Journal:  Compr Psychiatry       Date:  2010-01-08       Impact factor: 3.735

3.  Associations in the course of personality disorders and Axis I disorders over time.

Authors:  M Tracie Shea; Robert L Stout; Shirley Yen; Maria E Pagano; Andrew E Skodol; Leslie C Morey; John G Gunderson; Thomas H McGlashan; Carlos M Grilo; Charles A Sanislow; Donna S Bender; Mary C Zanarini
Journal:  J Abnorm Psychol       Date:  2004-11

Review 4.  [Personality, personality disorders and depression].

Authors:  K-T Kronmüller; C Mundt
Journal:  Nervenarzt       Date:  2006-07       Impact factor: 1.214

5.  A synopsis of the WPA Educational Program on Personality Disorders.

Authors:  Erik Simonsen; Elsa Ronningstam; Theodore Millon
Journal:  World Psychiatry       Date:  2008       Impact factor: 49.548

6.  Effects of personality disorders on functioning and well-being in major depressive disorder.

Authors:  Andrew E Skodol; Carlos M Grilo; Maria E Pagano; Donna S Bender; John G Gunderson; M Tracie Shea; Shirley Yen; Mary C Zanarini; Thomas H McGlashan
Journal:  J Psychiatr Pract       Date:  2005-11       Impact factor: 1.325

7.  The Structure of Personality Disorders within a Depressed Sample: Implications for Personalizing Treatment.

Authors:  Joanna M Berg; Jamie C Kennedy; Boadie W Dunlop; Cynthia L Ramirez; Lindsay M Stewart; Charles B Nemeroff; Helen S Mayberg; W Edward Craighead
Journal:  Pers Med Psychiatry       Date:  2017-01-05

8.  Premorbid Personality Disorders in Male Schizophrenic Patients with or without Comorbid Substance Use Disorder: Is Dual Diagnosis Mediated by Personality Disorder?

Authors:  Neslihan Altunsoy; Şafak Yalçın Şahiner; Merve Cingi Külük; Tuncer Okay; Semra Ulusoy Kaymak; Çiğdem Aydemir; Erol Göka
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

9.  Qualitative Analysis of Resources and Barriers Related to Treatment of Borderline Personality Disorder in the United States.

Authors:  Matthew C Lohman; Karen L Whiteman; Frank E Yeomans; Sheila A Cherico; Winifred R Christ
Journal:  Psychiatr Serv       Date:  2016-10-03       Impact factor: 3.084

Review 10.  Emotion-based dispositions to rash action: positive and negative urgency.

Authors:  Melissa A Cyders; Gregory T Smith
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.